(Q33329279)

25 July 2017

title

Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia (English)

1 reference

heparin-induced thrombocytopenia

25 July 2017

1 reference

1 reference

1 reference

Wallis DE

1

1 reference

25 July 2017

Workman DL

2

1 reference

25 July 2017

Lewis BE

3

1 reference

25 July 2017

Steen L

4

1 reference

25 July 2017

Pifarre R

5

1 reference

25 July 2017

Moran JF

6

1 reference

25 July 2017

language of work or name

English

0 references

publication date

1 June 1999

1 reference

American Journal of Medicine

25 July 2017

published in

1 reference

25 July 2017

volume

106

1 reference

25 July 2017

issue

6

1 reference

25 July 2017

page(s)

629-635

1 reference

Immune endothelial-cell injury in heparin-associated thrombocytopenia

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900124-2

Heparin-induced thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900124-2

Heparin-associated thrombocytopenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900124-2

Heparin induced thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900124-2

Heparin-Induced Thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900124-2

Complications from heparin-induced thrombocytopenia in patients undergoing cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900124-2

Heparin-induced thrombocytopenia, thrombosis, and hemorrhage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900124-2

Heparin-induced thrombocytopenia in open heart surgical patients: sequelae of late recognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900124-2

Heparin-associated thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900124-2

Platelet Factor 4: Production, Structure, and Physiologic and Immunologic Action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900124-2

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900124-2

Heparin-induced thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900124-2

Reduced morbidity and mortality rates of the heparin-induced thrombocytopenia syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900124-2

A 14-year study of heparin-induced thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900124-2

Heparin-Associated Thrombosis Without Thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900124-2

Rapid induction of hepatocyte growth factor by heparin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900124-2

Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900124-2

Thrombocytopenia in the intensive care unit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900124-2

Diagnosis of heparin-induced thrombocytopenia. Still a journey, not yet a destination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900124-2

The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900124-2

Heparin-induced thrombocytopenia and thrombosis: clinical and laboratory studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900124-2

Plasminogen activator inhibitor type 1: biochemistry and evidence for modulation of fibrinolysis in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900124-2

Characterization of the humoral immune response in heparin-induced thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900124-2

Transient thrombotic state after abrupt discontinuation of heparin in percutaneous coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900124-2

Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900124-2

Heparin-induced thrombocytopenia: association of thrombotic complications with heparin-dependent IgG antibody that induces thromboxane synthesis in platelet aggregation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900124-2

Anticardiolipin antibodies in heparin-associated thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900124-2

Single amino acid mutation of Fc gamma receptor is associated with the development of heparin-induced thrombocytopenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900124-2

The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin: a multi-institutional cohort study of patients who underwent hip or knee arthroplasty. Canadian Collaborative Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900124-2

Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900124-2

Anticoagulation with Novastan (argatroban) in patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900124-2

Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900124-2

Effect of glycoprotein IIb/IIIa antagonists on the HIT serum induced activation of platelets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900124-2

10.1016/S0002-9343(99)00124-2

7 January 2021

Identifiers

DOI

1 reference

25 July 2017

1 reference